Evidence map›Paper›PMID 35728895›Full record

ArticleBMJ open2022

Feasible approaches and implementation challenges to atrial fibrillation screening: a qualitative study of stakeholder views in 11 European countries.

Daniel Engler, Coral L Hanson, Lien Desteghe, Giuseppe Boriani, Søren Zöga Diederichsen, Ben Freedman, Elena Palà, Tatjana S Potpara, Henning Witt, Hein Heidbuchel and 3 more

Abstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Key stakeholder views on atrial fibrillation screening: a systematic mixed-studies review and interpretive analysis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Screening and detection of atrial fibrillation in primary care: current practice and future perspectives.European heart journal supplements : journal of the European Society of Cardiology · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daniel EnglerDepartment of Cardiology, University Medical Center Hamburg-Eppendorf, University Heart & Vascular Center Hamburg, Hamburg, Germany d.engler@uke.de.ORCID 0000-0002-9519-6258
Coral L HansonSchool of Health and Social Care, Edinburgh Napier University, Edinburgh, UK.ORCID 0000-0003-1602-1968
Lien DestegheHeart Center Hasselt, Jessa Hospital, Hasselt, Belgium.
Giuseppe BorianiCardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.ORCID 0000-0002-9820-4815
Søren Zöga DiederichsenDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.ORCID 0000-0002-9687-0857
Ben FreedmanHeart Research Institute, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-3809-2911
Elena PalàNeurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Autonomous University of Barcelona, Barcelona, Spain.
Tatjana S PotparaDeptartment for Intensive Arrhythmia Care, Cardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia.ORCID 0000-0001-6285-6902
Henning WittPfizer Pharma GmbH, Berlin, Germany.
Hein HeidbuchelDepartment of Cardiology, Antwerp University Hospital, Antwerp, Belgium.
Lis NeubeckSchool of Health and Social Care, Edinburgh Napier University, Edinburgh, UK.
Renate B SchnabelDepartment of Cardiology, University Medical Center Hamburg-Eppendorf, University Heart & Vascular Center Hamburg, Hamburg, Germany.ORCID 0000-0001-7170-9509
AFFECT-EU investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAtrial fibrillation (AF) screening may increase early detection and reduce complications of AF. European, Australian and World Heart Federation guidelines recommend opportunistic screening, despite a current lack of clear evidence supporting a net benefit for systematic screening. Where screening is implemented, the most appropriate approaches are unknown. We explored the views of European stakeholders about opportunities and challenges of implementing four AF screening scenarios.

designTelephone-based semi-structured interviews with results reported using Consolidated criteria for Reporting Qualitative research guidelines. Data were thematically analysed using the framework approach.

settingAF screening stakeholders in 11 European countries.

participantsHealthcare professionals and regulators (n=24) potentially involved in AF screening implementation.

interventionFour AF screening scenarios: single time point opportunistic, opportunistic prolonged, systematic single time point/prolonged and patient-led screening. PRIMARY OUTCOME MEASURES: Stakeholder views about the challenges and feasibility of implementing the screening scenarios in the respective national/regional healthcare system.

resultsThree themes developed. (1) Current screening approaches: there are no national AF screening programmes, with most AF detected in symptomatic patients. Patient-led screening exists via personal devices, creating screening inequity. (2) Feasibility of screening: single time point opportunistic screening in primary care using single-lead ECG devices was considered the most feasible. Software algorithms may aid identification of suitable patients and telehealth services have potential to support diagnosis. (3) Implementation requirements: sufficient evidence of benefit is required. National screening processes are required due to different payment mechanisms and health service regulations. Concerns about data security, and inclusivity for those without primary care access or personal devices must be addressed.

conclusionsThere is an overall awareness of AF screening. Opportunistic screening appears the most feasible across Europe. Challenges are health inequalities, identification of best target groups for screening, streamlined processes, the need for evidence of benefit and a tailored approach adapted to national realities.

Indexed as

Atrial FibrillationAustraliaElectrocardiographyHumansMass ScreeningQualitative Researchcardiac epidemiologygeneral medicine (see internal medicine)preventive medicinequality in health carerisk managementstroke

Identifiers

PMID35728895
PMCPMC9214372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.